Abstract
The bar-pressing behavior of hungry rats was maintained by a fixed-ratio schedule of food reinforcement. At 5 and 12 days after pretreatment with p-chlorophenylalanine (PCPA), a subtreshold dose (20 μg/kg) of lysergic acid diethylamide (LSD) was found to disrupt this behavior. No such disruption occurred when PCPA pretreatment was followed by either a distracting external stimulus (tone) or a low dose of D-amphetamine (0.3 mg/kg). Sensitivity to LSD was apparently unaffected by pretreatment with α-methyl-p-tyrosine (AMPT).
Similar content being viewed by others
References
Aghajanian, G. K., Foote, W. E., Sheard, M. H.: Action of psychotogenic drugs on single midbrain raphé neurons. J. Pharmacol. exp. Ther. 171, 178–187 (1970).
— — —: Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphé. Science 161, 706–708 (1968).
—, Rosecrans, J. A., Sheard, M. H.: Serotonin: release in the forebrain by stimulation of midbrain raphé. Science 156, 402–403 (1967).
—, Sheard, M. H.: Behavioral effects of midbrain raphé stimulation: dependence on serotonin. Comm. Behav. Biol., Part A, 1, 37–41 (1968).
Anden, N.-E., Corrodi, H., Fuxe, K., Hokfelt, T.: Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Brit. J. Pharmacol. 34, 1–7 (1968).
Appel, J. B.: The effects of “psychotomimetic” drugs on animal behavior. In: Psychopharmacology: a review of progress 1957–1967, pp. 1211–1222. D. Efron, ed. Washington, D. C.: U. S. Government Printing Office 1968.
—, Freedman, D. X.: Chemically-induced alterations in the behavioral effects of LSD-25. Biochem. Pharmacol. 13, 861–869 (1964).
— —: The relative potencies of psychotomimetic drugs. Life Sci. 4, 2181–2186 (1965).
— —: Tolerance and cross-tolerance among psychotomimetic drugs. Psychopharmacologia (Berl.) 13, 267–274 (1968).
Bogdanski, D. F., Pletscher, A., Brodie, B. B., Udenfriend, S.: Identification and assay of serotonin in brain. J. Pharmacol. exp. Ther. 117, 82–88 (1956).
Dahlstrom, A., Fuxe, K.: Evidence for the existence of monoamine containing neurons in the central nervous system. Acta physiol. scand. 62, 1–55 (1965).
Delormé, F., Froment, J. L., Jouvet, M.: Suppression du sommeil par la P. chloromethamphétamine et la P. chlorophenylalanine. C.R. Soc. Biol. (Paris) 180, 2347–2351 (1966).
Ferguson, J., Hendriksen, S., Cohn, H., Mitchell, G., Barchas, J., Dement, W.: “Hypersexuality” and behavioral changes in cats caused by administration of p-chlorophenylalanine. Science 168, 499–501 (1970).
Ferster, C. B., Skinner, B. F.: Schedules of reinforcement. New York: Appleton-Century-Crofts 1957.
Freedman, D. X.: Effects of LSD-25 on brain serotonin. J. Pharmacol. exp. Ther. 134, 160–166 (1961).
—: Aspects of the biochemical pharmacology of psychotropic drugs. In: Psychiatric Drugs, pp. 32–57. P. Solomon, ed. New York: Grune and Stratton 1966.
—, Aghajanian, G. K.: Biochemical pharmacology of LSD-25. Lloydia 29, 309–314 (1966).
—, Appel, J. B., Hartman, F. R., Molliver, M. E.: Tolerance to behavioral effects of LSD-25 in rat. J. Pharmacol. exp. Ther. 143, 309–313 (1964).
—, Gottlieb, R., Lovell, R. A.: Psychotomimetic drugs and brain 5-hydroxytryptamine metabolism. Biochem. Pharmacol. 19, 1181–1188 (1970).
Gaddum, J. H.: Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine. J. Physiol. (Lond.) 121, 15P (1953).
Harvey, J. A., Heller, A., Moore, R. Y.: The effect of unilateral and bilateral medial forebrain bundle lesions on brain serotonin. J. Pharmacol. exp. Ther. 140, 103–110 (1963).
—, Lints, C. E.: Lesions in the medial forebrain bundle: delayed effects on sensitivity to shock. Science 148, 250–252 (1965).
Horita, A., Hamilton, A. E.: Lysergic acid diethylamide: dissociation of its behavioral and hyperthermic actions by DL-α-methyl-p-tyrosine. Science 164, 78–79 (1969).
Jarvik, M. E.: The behavioral effects of psychotogens. In: LSD, Man, and Society, pp. 186–206. R. C. Debold and R. C. Leaf, eds. Middletown, Connecticut: Wesleyan University Press 1967.
Jequier, E., Lovenberg, W., Sjoerdsma, A.: Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Molec. Pharmacol. 3, 274–278 (1967).
Koe, B. K., Weissman, A.: p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. exp. Ther. 154, 499–516 (1966).
Lints, C. E., Harvey, J. A.: Altered sensitivity to foot-shock and decreased brain content of serotonin following brain lesions in the rat., J. comp. physiol. Psychol. 67, 23–31 (1969).
Lipton, M. A., Guroff, R. G., Udenfriend, S.: p-Chlorophenylalanine-induced chemical manifestations of phenylketonuria in rats. Science 156, 248–250 (1967).
Mead, J. A. R., Finger, K. F.: A simple extraction method for the determination of both norepinephrine and serotonin in brain. Biochem. Pharmacol. 6, 52–53 (1961).
Mouret, J., Bobillier, P., Jouvet, M.: Effects de la parachlorophenylalanine sur le sommeil du rat. C. R. Soc. Biol. (Paris) 161, 1600–1603 (1967).
Pletscher, A., Bartholini, G., Bruderer, H., Burkhard, W. P., Gey, K. F.: Chlorinated arylalkylamines affecting the cerebral metabolism of 5-hydroxytryptamine. J. Pharmacol. exp. Ther. 145, 344–350 (1964).
—, Da Prada, M., Bartholini, G., Burkard, W. P., Bruderer, H.: Two types of monoamine liberation by chlorinated arylalkylamines. Life Sci. 4, 2301–2308 (1965).
Rechtschaffen, A., Lovell, R. A., Freedman, D. X., Whitehead, P. K., Aldrich, M.: Effects of parachlorophenylalanine (PCPA) on sleep in rats. Psychophysiology 6, 233 (1969).
Rosecrans, J. A., Lovell, R. A., Freedman, D. X.: Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine. Biochem. Pharmacol. 16, 2011–2021 (1967).
Rosen, A. J., Buga, J.: Effects of brain serotonin manipulation on multiple schedule performance in the rat. Arch. int. Pharmacodyn. 180, 299–308 (1969).
Sheard, M. H.: The effect of p-chlorophenylalanine on behavior in rats: relation to brain serotonin and 5-hydroxyindoleacetic acid. Brain Res. 15, 524–528 (1969).
—, Aghajanian, G. K.: Stimulation of midbrain raphé neurons: behavioral effects of serotonin release. Life Sci. 7, 19–25 (1968).
—, Freedman, D. X.: The effects of CNS lesions on norepinephrine serotonin, and acetylcholine in brain. Brain Res. 3, 292–294 (1966/1967).
Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by α-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 147, 86–95 (1965).
Stevens, D. A., Resnick, O., Krus, D. M.: The effects of p-chlorophenylalanine, a depletor of brain serotonin, on behavior. I. Facilitation of discrimination learning. Life Sci. 6, 2215–2220 (1967).
Tagliamonte, A., Tagliamonte, P., Gessa, G. L., Brodie, B. B.: Compulsive sexual activity induced by p-chlorophenylalanine in normal and pinealectomized rats. Science 166, 1433–1435 (1969).
Tenen, S. S.: The effects of p-chlorophenylalanine, a serotonin depletor on avoidance acquisition, pain sensitivity and related behavior in the rat. Psychopharmacologia (Berl.) 10, 204–219 (1967).
Udenfriend, S., Weissbach, H., Brodie, B. B.: Assay of serotonin and related metabolites, enzymes, and drugs. In: Methods of Biochemical Analysis, vol. VI, pp. 95–130. D. Glick, ed. New York: Interscience 1958.
Welch, A. S., Welch, B. L.: Effect of p-chlorophenylalanine on brain noradrenaline in mice. J. Pharm. Pharmacol. 19, 632–633 (1967).
Woolley, D. W., Shaw, E. A.: A biochemical and pharmacological suggestion about certain mental disorders. Proc. nat. Acad. Sci. (Wash.) 40, 228–231 (1954).
Author information
Authors and Affiliations
Additional information
This work was supported by USPHS Research Grant MH 13, 186 from the National Institute of Mental Health and by grant NSF GB 7442 from the National Science Foundation.
Supported by USPHS Research Scientist Development Award 5-KO2-MH-09355 from the National Institute of Mental Health.
Supported in part by a research fellowship from The Schweppe Foundation.
Rights and permissions
About this article
Cite this article
Appel, J.B., Lovell, R.A. & Freedman, D.X. Alterations in the behavioral effects of LSD by pretreatment with p-chlorophenylalanine and α-methyl-p-tyrosine. Psychopharmacologia 18, 387–406 (1970). https://doi.org/10.1007/BF00402765
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00402765